Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Withdrawal risk during a recession can threaten income stability. This overview highlights risk factors and straightforward mitigation approaches.
26,857 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Institutional hands move in the ETF space as second line capital buys into a short-maturity strategy. This article br...
A major fund slashed its stake in Papa John's, triggering questions about the stock's outlook. This guide explains wh...
As markets wobble in early 2026, preferred shares matter for investors seeking steady income and lower drama than gro...
River Road Asset Management just added a notable new position in AptarGroup, acquiring 917,670 shares valued at about...
When the world's wealthiest fund managers move, markets listen. This deep dive explains how the latest 13F season sho...
A sudden explosion at Valero’s Port Arthur refinery prompted a temporary shutdown, sending ripples through energy mar...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
ARK’s latest AI IPO move put Cerebras at the center of a hype-filled market. Before you copy a big bet, learn the rea...
When A-list stars anchor niche sports stories, it signals a shift in entertainment investing. This article unpacks wh...
MetaMask steps into the AI era with an agent wallet designed for self-custody and safer automated DeFi trading. This ...
A wave of bitcoin etfs outflows billion sent ripples through the market. This guide breaks down what happened, why it...